Načítá se...
Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries
Data from a large multicenter observational study of patients with multidrug-resistant tuberculosis (MDR TB) were analyzed to simulate the possible use of 2 new approaches to treatment of MDR TB: a short (9-month) regimen and a bedaquiline-containing regimen. Of 1,254 patients, 952 (75.9%) had no re...
Uloženo v:
| Vydáno v: | Emerg Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Centers for Disease Control and Prevention
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4451908/ https://ncbi.nlm.nih.gov/pubmed/25988299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2106.141329 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|